Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to -$10.3 million.

  • LifeStance Health's Cash from Investing Activities fell 10374.18% to -$10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.5 million, marking a year-over-year decrease of 1812.66%. This contributed to the annual value of -$21.6 million for FY2024, which is 6425.92% up from last year.
  • Per LifeStance Health's latest filing, its Cash from Investing Activities stood at -$10.3 million for Q3 2025, which was down 10374.18% from -$7.8 million recorded in Q2 2025.
  • Over the past 5 years, LifeStance Health's Cash from Investing Activities peaked at -$5.1 million during Q3 2024, and registered a low of -$79.6 million during Q4 2021.
  • Its 5-year average for Cash from Investing Activities is -$19.9 million, with a median of -$11.4 million in 2023.
  • Per our database at Business Quant, LifeStance Health's Cash from Investing Activities plummeted by 32970.0% in 2022 and then surged by 8147.3% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Cash from Investing Activities stood at -$79.6 million in 2021, then surged by 61.92% to -$30.3 million in 2022, then soared by 62.33% to -$11.4 million in 2023, then soared by 44.8% to -$6.3 million in 2024, then tumbled by 63.32% to -$10.3 million in 2025.
  • Its Cash from Investing Activities was -$10.3 million in Q3 2025, compared to -$7.8 million in Q2 2025 and -$7.2 million in Q1 2025.